Menu
GeneBe

ADAM19

ADAM metallopeptidase domain 19, the group of ADAM metallopeptidase domain containing

Basic information

Region (hg38): 5:157395533-157575775

Links

ENSG00000135074NCBI:8728OMIM:603640HGNC:197Uniprot:Q9H013AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ADAM19 gene.

  • Inborn genetic diseases (40 variants)
  • not provided (9 variants)
  • Lung adenocarcinoma (3 variants)
  • Squamous cell carcinoma (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAM19 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
39
clinvar
2
clinvar
4
clinvar
45
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
5
clinvar
5
Total 0 0 44 3 5

Variants in ADAM19

This is a list of pathogenic ClinVar variants found in the ADAM19 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-157459690-C-T Benign (Jun 19, 2021)1276066
5-157459811-G-C Benign (Jun 20, 2021)1222176
5-157459842-A-G Benign (Nov 12, 2018)1228213
5-157459885-C-T Benign (Jun 20, 2021)1267802
5-157460014-C-A Autosomal recessive congenital ichthyosis 6 Uncertain significance (Jan 12, 2018)903911
5-157460037-C-T Autosomal recessive congenital ichthyosis 6 Uncertain significance (Jan 12, 2018)903912
5-157460094-C-T Autosomal recessive congenital ichthyosis 6 Likely benign (Jan 13, 2018)352503
5-157460111-C-A Autosomal recessive congenital ichthyosis 6 Uncertain significance (Jan 13, 2018)903913
5-157460125-A-G not specified • Autosomal recessive congenital ichthyosis 6 Benign (Jan 13, 2018)257433
5-157460136-T-C Autosomal recessive congenital ichthyosis 6 Pathogenic (May 16, 2019)638533
5-157460192-C-T Inborn genetic diseases Uncertain significance (May 17, 2023)2515493
5-157460193-C-A Inborn genetic diseases Uncertain significance (Jan 30, 2024)3200166
5-157460197-G-A Autosomal recessive congenital ichthyosis 6 Uncertain significance (Jan 13, 2018)352504
5-157460209-C-T Benign (May 23, 2023)2763581
5-157460212-C-A Autosomal recessive congenital ichthyosis 6 Benign/Likely benign (Oct 27, 2021)352505
5-157460218-CTCGC-T not specified Uncertain significance (Dec 23, 2021)1331474
5-157460228-A-C Inborn genetic diseases Uncertain significance (Mar 21, 2023)2527568
5-157460241-A-G Uncertain significance (Aug 05, 2019)1307671
5-157460250-G-A Autosomal recessive congenital ichthyosis 6 Uncertain significance (Nov 06, 2017)905798
5-157460262-C-T Benign (Apr 08, 2022)1669807
5-157460300-G-A Inborn genetic diseases Uncertain significance (Dec 20, 2023)3200159
5-157460324-G-T Lamellar ichthyosis Likely pathogenic (Sep 16, 2022)1722366
5-157460331-G-A not specified Uncertain significance (May 31, 2023)2506247
5-157460331-G-C Inborn genetic diseases Likely benign (Sep 14, 2023)2624350
5-157460362-G-C Autosomal recessive congenital ichthyosis 6 Pathogenic (May 16, 2019)638534

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ADAM19protein_codingprotein_codingENST00000257527 23180242
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00006801.001257010471257480.000187
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.884095310.7700.00003045970
Missense in Polyphen133206.890.642862345
Synonymous0.4652032120.9590.00001331806
Loss of Function4.401750.90.3340.00000293557

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003920.000366
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.00009240.0000924
European (Non-Finnish)0.0002740.000264
Middle Eastern0.0001090.000109
South Asian0.00009800.0000980
Other0.0003580.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Participates in the proteolytic processing of beta-type neuregulin isoforms which are involved in neurogenesis and synaptogenesis, suggesting a regulatory role in glial cell. Also cleaves alpha-2 macroglobulin. May be involved in osteoblast differentiation and/or osteoblast activity in bone (By similarity). {ECO:0000250}.;
Pathway
Mesodermal Commitment Pathway;Invadopodia formation;Extracellular matrix organization (Consensus)

Recessive Scores

pRec
0.131

Intolerance Scores

loftool
0.452
rvis_EVS
0.92
rvis_percentile_EVS
89.57

Haploinsufficiency Scores

pHI
0.715
hipred
Y
hipred_score
0.682
ghis
0.504

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.440

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Adam19
Phenotype
endocrine/exocrine gland phenotype; muscle phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
placenta development;membrane protein ectodomain proteolysis;positive regulation of gene expression;extracellular matrix organization;positive regulation of cell-cell adhesion mediated by cadherin
Cellular component
nucleus;Golgi apparatus;plasma membrane;integral component of membrane;collagen-containing extracellular matrix
Molecular function
metalloendopeptidase activity;protein binding;SH3 domain binding;metal ion binding